Real-world treatment patterns in third-line patients with metastatic renal cell carcinoma (mRCC): The changing landscape in the United States.
Sumanta Kumar Pal
Consultant or Advisory Role - Novartis; Novartis; Novartis
Honoraria - Novartis; Novartis; Novartis
Elisabetta Malangone
Employment or Leadership Position - LA-SER Analytica; LA-SER Analytica; LA-SER Analytica
Consultant or Advisory Role - LA-SER Analytica; LA-SER Analytica; LA-SER Analytica
Sharvari Bhurke
Employment or Leadership Position - LA-SER Analytica; LA-SER Analytica; LA-SER Analytica
Consultant or Advisory Role - LA-SER Analytica; LA-SER Analytica; LA-SER Analytica
Magdaliz Gorritz
Employment or Leadership Position - LA-SER Analytica; LA-SER Analytica; LA-SER Analytica
Consultant or Advisory Role - LA-SER Analytica; LA-SER Analytica; LA-SER Analytica
Lee Stern
Employment or Leadership Position - LA-SER Analytica
Research Funding - LA-SER Analytica; LA-SER Analytica received funding for this research from Novartis; LA-SER Analytica received funding for this research from Novartis; Novartis
John Coombs
Employment or Leadership Position - Novartis; Novartis; Novartis
Stock Ownership - Novartis; Novartis; Novartis
James D. Turnbull
Employment or Leadership Position - Novartis; Novartis
Xufang Wang
Employment or Leadership Position - Novartis; Novartis
Stock Ownership - Novartis; Novartis; Novartis
Zhimei Liu
Employment or Leadership Position - Novartis; Novartis
Stock Ownership - Novartis; Novartis